Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Revenue projections:

Revenue projections for DVA
Revenue projections for DVA

Revenues for DVA are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 1.292000
forwardPE 9.460546
debtToEquity 1111.353000
earningsGrowth 0.065000
revenueGrowth 0.099000
grossMargins 0.322550
operatingMargins 0.152280
trailingEps 9.510000
forwardEps 16.398630

The current ratio for DVA is 1.292, indicating that the company can service its short-term debt using available cash and assets. This suggests DVA has strong liquidity, with more than enough resources to meet its immediate financial commitments.
DVA's elevated debt-to-equity ratio highlights its heavy reliance on debt. This high leverage increases the company's exposure to financial risk, making it more vulnerable to market fluctuations and economic downturns.
DaVita Inc.'s forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that DaVita Inc. is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for DVA
Price projections for DVA

DVA's price has continuously remained near the lower end of analysts' projections, indicating that it may be facing challenges in meeting market expectations. This trend raises concerns about the company's future growth trajectory.

Insider Transactions:

Insider Transactions for DVA
Insider Transactions for DVA


6 DVA stock sales were completed, with market price of 135.33333460489908.There were no sell transactions throughout the period under consideration.The recent trend of increased buying at DVA's current price levels may indicate a favorable market sentiment. This could point to a positive outlook for the stock, as investors show growing confidence through higher buy activity.

Recommendation changes over time:

Recommendations trend for DVA
Recommendations trend for DVA


DVA has faced a sell bias from analysts recently, indicating that caution is advised. Investors should expand their focus to a broader set of market indicators when making decisions, ensuring a well-rounded approach rather than acting solely on one piece of analysis.